The evolution from ICH E6 (R2) to (R3) represents a fundamental shift in clinical trial management, moving from reactive compliance to a proactive Quality by Design (QbD) and risk-based approach. Central to this new mandate is the requirement for robust data governance across the entire clinical data lifecycle, ensuring integrity, traceability, and security from capture to archival.

This session explores how the Egnyte for Life Sciences platform addresses these advanced requirements by bridging the gap between IT-level data oversight and quality-driven document control.

We will demonstrate how a unified environment can:

Implement Modern Data Governance
Strengthen Document Control
Enable Risk-Proportionate Oversight
Foster a Culture of Quality

Join us to learn how to transform your compliance posture from a series of isolated tasks into an integrated, inspection-ready ecosystem built for the next generation of clinical research.

Don’t miss your chance to uncover best practices for Data Governance for biotechs today!

Confirmed registrants will receive a $35 lunch gift card to enjoy after the conversation.